Equity (Details) - USD ($) $ / shares in Units, shares in Thousands |
6 Months Ended | |
|---|---|---|
May 02, 2022 |
Dec. 31, 2022 |
|
| Equity (Details) [Line Items] | ||
| Weighted average fair value grant date | $ 1.87 | |
| Equity incentive plan [Member] | ||
| Equity (Details) [Line Items] | ||
| Shares of common stock | 235 | |
| Restricted stock units | 390 | |
| Weighted average fair value grant date | $ 7.86 | |
| Employee Stock Purchase Plan [Member] | ||
| Equity (Details) [Line Items] | ||
| Vesting period | 3 years | |
| Minimum [Member] | ||
| Equity (Details) [Line Items] | ||
| Vesting period | 4 years | |
| Vesting percentage | 0.00% | |
| Maximum [Member] | ||
| Equity (Details) [Line Items] | ||
| Vesting period | 5 years | |
| Vesting percentage | 200.00% | |
| ATM Sales Agreement [Member] | ||
| Equity (Details) [Line Items] | ||
| Aggregate offering price | $ 50,000,000 | |
| Restricted Stock Units [Member] | ||
| Equity (Details) [Line Items] | ||
| Restricted stock units | 1,000 | |
| Weighted average fair value grant date | $ 3.51 |
| X | ||||||||||
- Definition The amount of aggregate offering price. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of excess stock shares of an entity that have been sold or granted to shareholders. No definition available.
|
| X | ||||||||||
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Purchase price of common stock expressed as a percentage of its fair value. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|